Oral diseases · 2026
The Role of Type H Vessels in Oral Diseases.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Hengyuan, Wu Zuping, Song Ruifeng, Chen Siyu, Guan Guzhe, Chen Qian, Kang Ting, Feng Xiaoxia
Аннотация
OBJECTIVE: This review aims to elucidate the biological significance of Type H vessels, a specialized bone marrow vascular subtype characterized by high expression of endothelial mucin (Emcn) and PECAM-1/CD31, and their critical role in coupling angiogenesis with osteogenesis. We also discuss their therapeutic potential in craniomaxillofacial trauma and alveolar bone loss.
METHODS: This is a narrative review. we identified relevant studies by searching PubMed (MEDLINE) and Web of Science using combinations of keywords related to CD31/Endomucin (Type H Vessels), angiogenic-osteogenic coupling, and oral/craniofacial conditions, and by screening reference lists of key articles.
RESULTS: The central role of Type H Vessels in skeletal biology underscores therapeutic promise for mitigating bone loss in periodontitis and other oral pathologies.
CONCLUSIONS: Type H Vessels are emerging regulators of angiogenic-osteogenic coupling in skeletal tissues. Although bone and craniofacial tissues are similar and craniofacial evidence is growing, It remains less extensive than long-bone mechanistic studies; therefore, translational strategies in oral medicine should be interpreted in light of this evidence gap. This review consolidates mechanistic and clinical evidence, proposing novel strategies to harness the angiogenic-osteogenic coupling for oral rehabilitation of bone-destructive diseases. Future research should explore precise modulation of Type H Vessels to optimize therapeutic outcomes.
METHODS: This is a narrative review. we identified relevant studies by searching PubMed (MEDLINE) and Web of Science using combinations of keywords related to CD31/Endomucin (Type H Vessels), angiogenic-osteogenic coupling, and oral/craniofacial conditions, and by screening reference lists of key articles.
RESULTS: The central role of Type H Vessels in skeletal biology underscores therapeutic promise for mitigating bone loss in periodontitis and other oral pathologies.
CONCLUSIONS: Type H Vessels are emerging regulators of angiogenic-osteogenic coupling in skeletal tissues. Although bone and craniofacial tissues are similar and craniofacial evidence is growing, It remains less extensive than long-bone mechanistic studies; therefore, translational strategies in oral medicine should be interpreted in light of this evidence gap. This review consolidates mechanistic and clinical evidence, proposing novel strategies to harness the angiogenic-osteogenic coupling for oral rehabilitation of bone-destructive diseases. Future research should explore precise modulation of Type H Vessels to optimize therapeutic outcomes.